192 related articles for article (PubMed ID: 9765353)
1. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species.
Tsao LI; Ladenheim B; Andrews AM; Chiueh CC; Cadet JL; Su TP
J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353
[TBL] [Abstract][Full Text] [Related]
2. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
[TBL] [Abstract][Full Text] [Related]
3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
[TBL] [Abstract][Full Text] [Related]
5. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
7. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
Tsao LI; Cadet JL; Su TP
Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030
[TBL] [Abstract][Full Text] [Related]
8. Rapid and reversible effects of methamphetamine on dopamine transporters.
Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
Vinayek R; Brown DR; Miller RJ
J Pharmacol Exp Ther; 1985 Mar; 232(3):781-5. PubMed ID: 2983070
[TBL] [Abstract][Full Text] [Related]
10. The effects of methamphetamine on the production of free radicals and oxidative stress.
Yamamoto BK; Zhu W
J Pharmacol Exp Ther; 1998 Oct; 287(1):107-14. PubMed ID: 9765328
[TBL] [Abstract][Full Text] [Related]
11. Free radical production induced by methamphetamine in rat striatal synaptosomes.
Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
[TBL] [Abstract][Full Text] [Related]
12. Picomolar concentrations of hibernation induction delta opioid peptide [D-Ala2,D-Leu5]enkephalin increase the nerve growth factor in NG-108 cells.
Tsai SY; Hayashi T; Su TP
Synapse; 2005 Sep; 57(3):179-81. PubMed ID: 15945062
[TBL] [Abstract][Full Text] [Related]
13. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
14. Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia.
Wang S; Duan Y; Su D; Li W; Tan J; Yang D; Wang W; Zhao Z; Wang X
Eur J Pharmacol; 2011 May; 658(2-3):140-4. PubMed ID: 21349267
[TBL] [Abstract][Full Text] [Related]
15. [Protective effects of a delta-opioid-receptor agonist and an oxygen radical scavenger on postischemic hearts].
Schipke JD; Nickel F; Gams E; Sunderdiek U
Herz; 2004 May; 29(3):331-40. PubMed ID: 15167961
[TBL] [Abstract][Full Text] [Related]
16. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
[TBL] [Abstract][Full Text] [Related]
17. Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: linking hibernation and neuroprotection.
Borlongan CV; Wang Y; Su TP
Front Biosci; 2004 Sep; 9():3392-8. PubMed ID: 15353366
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
Belcheva MM; Barg J; McHale RJ; Gao XM; Chuang DM; Coscia CJ
J Pharmacol Exp Ther; 1991 Oct; 259(1):302-9. PubMed ID: 1656025
[TBL] [Abstract][Full Text] [Related]
19. Delta opioid receptors stimulation with [D-Ala2, D-Leu5] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia.
Iwata M; Inoue S; Kawaguchi M; Kurita N; Horiuchi T; Nakamura M; Konishi N; Furuya H
Neurosci Lett; 2007 Mar; 414(3):242-6. PubMed ID: 17207574
[TBL] [Abstract][Full Text] [Related]
20. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
Kitamura O
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S63-5. PubMed ID: 19269222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
